文献速递细胞病理与分子病理神经与头颈病理

细针穿刺后梗死性嗜酸细胞甲状腺肿瘤中线粒体DNA「共同缺失」研究

Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
PubMed 文献 · Hum Pathol · 2017-09-27

该研究比较了细针穿刺后发生广泛梗死的嗜酸细胞甲状腺肿瘤与无梗死的对照组,发现梗死组肿瘤较大(P = .03),但线粒体DNA共同缺失发生率显著更低(25% vs 72.7%,P = .05),提示线粒体DNA缺失可能赋予嗜酸细胞在应激条件下的生存优势。

要点

  • 穿刺后广泛梗死的嗜酸细胞肿瘤体积显著大于无梗死对照组(P = .03)。
  • 梗死组线粒体DNA共同缺失仅25%,显著低于对照组72.7%(P = .05)。
  • 线粒体DNA缺失可能使嗜酸细胞在穿刺等应激下更具存活优势。

核心结论

  • 发生广泛梗死的嗜酸细胞肿瘤较无缺血改变者更小,且线粒体DNA共同缺失比例显著更低。
  • 线粒体DNA缺失可能赋予嗜酸细胞在应激条件(包括细针穿刺)下的生存优势。

研究设计与样本

  • 回顾性比较研究,从257例有配对细针穿刺和手术标本的嗜酸细胞肿瘤中筛选病例。
  • 梗死组为8例术后结节广泛(≥80%)梗死或坏死的病例(4例腺瘤、1例癌、3例恶性未定)。
  • 对照组为11例无穿刺后缺血/出血改变的肿瘤(9例腺瘤、1例癌、1例恶性潜能未定的滤泡性肿瘤)。

主要发现

  • 梗死组8例中2例(25%)检出线粒体DNA共同缺失。
  • 对照组11例中8例(72.7%)检出共同缺失,组间差异P = .05。
  • 10例存在缺失的病例中,7例邻近非肿瘤实质也检出共同缺失。
  • 梗死组肿瘤体积显著大于对照组(P = .03)。

临床怎么用

  • 病理诊断穿刺后广泛梗死的嗜酸细胞肿瘤时,应意识到其线粒体DNA共同缺失检出率可能较低。
  • 对梗死性嗜酸细胞肿瘤的分子检测结果解读需结合穿刺史和梗死程度。

局限性

  • 梗死组样本量小(8例),结论需更大样本验证。
  • 为单中心回顾性设计,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thyroid fine needle aspiration (FNA) can rarely induce morphological changes potentially hindering the histopathological diagnosis, especially in Hurthle cell tumors (HCTs), which may easily undergo post-FNA infarction or necrosis. HCTs contain mitochondrion (mt)-rich cells that may bear mtDNA mutations, the most frequent being the so-called common deletion (CD). The aim of this study was to determine the presence and extent of the mtDNA CD in a series of thyroid HCTs that underwent extensive infarction following FNA procedure in comparison with a control series of HCTs lacking post-FNA ischemic/hemorrhagic alterations. Of 257 HCTs with available matched FNA and surgical specimens, 8 cases showed extensive (≥80%) infarction or necrosis in the resected nodule (4 adenomas, 1 carcinoma, 3 HCTs undefined for malignancy). Noninfarcted tumors in the control series included 9 adenomas, 1 carcinoma, and 1 follicular tumor of uncertain malignant potential. These lesions were significantly (P = .03) larger than infarcted nodules. The mtDNA CD was identified using semiquantitative real-time polymerase chain reaction in 2 of 8 (25%) infarcted tumors. In HCTs lacking infarction/necrosis of the control series, the CD was significantly (P = .05) more common (8/11 cases, 72.7%). In 7 of the 10 deleted cases, the CD was present also in the adjacent nonneoplastic parenchyma. In conclusion, the rare oncocytic tumors undergoing extensive infarction are smaller than those lacking ischemic changes and bear the mtDNA CD in a significantly lower proportion compared with control noninfarcted HCTs. This may suggest that mtDNA deletion confers a survival advantage to oncocytic cells in stress conditions, including FNA procedures.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Conti L, Vatrano S, Bertero L, et al. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors. Hum Pathol. 2017. PMID: 28962946. doi:10.1016/j.humpath.2017.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。